Research on Traditional Chinese Medicine (TCM) Clinical Treatment of the Acute Episode of Bronchial Asthma.

Liaoning University of Traditional Chinese Medicine360 enrolled

Overview

Bronchial asthma is a common disease and frequently encountered disease of respiratory apparatus. It has very complex mechanism and multiple inducing factors. This study will focus on a new Chinese therapy on Bronchial asthma, analyzing the treatment mechanism of internal and external use, based on Traditional Chinese Medicine (TCM) theory and clinical practice. The study will also investigate the efficacy of the Chinese drugs and treatments on Bronchial asthma, and provide an effective therapy for this disease.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

360

Conditions

Bronchial Asthma

Interventions

warming lung and relieving asthmatic granule and Securing origin and warming lung emplastrum

clearing lung and relieving asthmatic granule and securing origin and clearing lung emplastrumOTHER

clearing lung and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and clearing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day

securing origin and relieving asthmatic granule and securing origin and nourishing lung emplastrumOTHER

securing origin and relieving asthmatic granule: once 1 bag, 3 times a day. securing origin and nourishing lung emplastrum: paste on acupuncture point and take the emplastrum down after 3 hours, once a day

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age between 18 to 65 years old; * Patients with mild-to-moderate bronchial asthma on attacking stage; * Without cardiopulmonary or other complications; * To comply with the diagnostic standard of bronchial asthma in western medicine and TCM syndrome differentiation; * Informed consent form is required to be signed. Exclusion Criteria: * Older than 65 years or younger than 18 years old; * Pregnant woman or suckling period woman; * Patients combine serious primary disease in liver, renal, cardiovascular and cerebrovascular, hemopoietic system diseases,or psychosis. * Severe levels of disease is between severe and critical extent. Combine Pulmonary Heart Disease or respiratory failure; * Irritable the physique, or allergic to the given composition of drugs in this research; * Patients who are in the process of other clinical research.

Outcomes

Primary Outcomes

primary Symptom

Symptom: wheezing, cough, choking

Time frame: 30 days

physical sign

physical sign: wheezing sound

Time frame: 30 days

assistant examination

Pulmonary function: mend matters of FEV1, PEF, FEV1/FVC

Time frame: 30 days

Secondary Outcomes

Secondary Symptom

Symptom: expectoration, fever, Aversion to wind and cold

Time frame: 30 days

physical sign

physical sign: tongue appearance and Pulse condition

Time frame: 30 days